Risk factors for cytomegalovirus gastrointestinal diseases in adult patients with cancer
Autor: | Jae-Hoon Ko, Jae-Hoon Song, Doo Ryeon Chung, C. W. Jung, Jeong Rae Yoo, Sun Young Cho, Nam Yong Lee, W. J. Lee, K. Kim, Y.-H. Kim, K.-M. Kim, Cheol-In Kang, K. R. Peck, Kyungmin Huh, Young Eun Ha |
---|---|
Rok vydání: | 2014 |
Předmět: |
Adult
Male Microbiology (medical) medicine.medical_specialty Abdominal pain medicine.medical_treatment Congenital cytomegalovirus infection Hematopoietic stem cell transplantation Disease Risk Factors Neoplasms Internal medicine Humans Medicine Aged Aged 80 and over business.industry Incidence Incidence (epidemiology) Transfusion Reaction Cancer General Medicine Odds ratio Middle Aged medicine.disease Gastroenteritis Surgery Diarrhea Infectious Diseases Case-Control Studies Cytomegalovirus Infections Female medicine.symptom business |
Zdroj: | European Journal of Clinical Microbiology & Infectious Diseases. 33:1847-1853 |
ISSN: | 1435-4373 0934-9723 |
DOI: | 10.1007/s10096-014-2107-x |
Popis: | Cytomegalovirus (CMV) gastrointestinal (GI) disease has been noticed frequently in cancer patients, causing abdominal pain, diarrhea, and GI bleeding. However, little is known about its actual incidence, clinical presentation, and the risk factors for its development among cancer patients. To answer these questions, we analyzed all cases that occurred during an 18-year period at our center. A case-control study was performed to identify risk factors for CMV GI disease. Electronic medical records were reviewed from individuals who were admitted and diagnosed with CMV GI disease during the period of January 1995 through March 2013 at a tertiary care center. Two CMV disease-free cancer patients were matched as controls. A total of 98 episodes of CMV GI disease were included in this study, and the overall incidence rate was 52.5 per 100,000 cancer patients, with an increasing trend throughout the study period. According to multivariate analysis, male sex, low body mass index, lymphopenia, hematological malignancy, and steroid use and red blood cell transfusion within 1 month prior to the CMV disease were identified to be independent risk factors. Among these factors, RBC transfusion showed the highest odds ratio (OR = 5.09). Male sex, low body mass index, lymphopenia, hematological malignancy, steroid use, and red blood cell transfusion within 1 month prior to the CMV disease diagnosis were independent risk factors for the development of CMV GI disease in adult patients with cancer. |
Databáze: | OpenAIRE |
Externí odkaz: |